Sigma Healthcare Limited (ASX:SIG)
Australia flag Australia · Delayed Price · Currency is AUD
2.705
-0.045 (-1.64%)
Mar 11, 2026, 2:49 PM AEST

Sigma Healthcare Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
9,5476,0023,2943,0912,9932,420
Revenue Growth (YoY)
208.89%82.18%6.59%3.27%23.67%-3.48%
Cost of Revenue
7,7764,5622,2512,1731,9211,752
Gross Profit
1,7711,4401,043917.71,072668.3
Selling, General & Admin
879.36671.08490.3488.97497.82737.83
Operating Expenses
879.36671.08490.3488.97497.82737.83
Operating Income
891.42769.21552.65428.73574.54-69.53
Interest Expense
-118.25-91.74-64.23-53.66-39.23-36.93
Interest & Investment Income
50.4850.4844.9418.423.8529.65
Earnings From Equity Investments
31.6630.2123.0613.048.181.65
Other Non Operating Income (Expenses)
34.9831.9517.722.832.656.47
EBT Excluding Unusual Items
890.28790.12574.12429.36550-68.69
Merger & Restructuring Charges
-46.62-46.62----
Other Unusual Items
-----1.29
Pretax Income
843.66743.49574.12429.36550-67.4
Income Tax Expense
246.99218.0434.46126.9164.99109.34
Earnings From Continuing Operations
596.67525.46539.66302.46385.01-176.74
Minority Interest in Earnings
3.144.461.361.870.920.76
Net Income
599.81529.91541.01304.33385.93-175.98
Net Income to Common
599.81529.91541.01304.33385.93-175.98
Net Income Growth
97.09%-2.05%77.77%-21.14%--
Shares Outstanding (Basic)
11,28110,4789,8261,5531,5511,125
Shares Outstanding (Diluted)
11,29310,4859,8261,5531,5531,127
Shares Change (YoY)
627.02%6.70%532.62%-37.84%8.22%
EPS (Basic)
0.050.050.060.200.25-0.16
EPS (Diluted)
0.050.050.060.200.25-0.16
EPS Growth
-72.86%-8.05%-71.93%-21.24%--
Free Cash Flow
440.64546.27240.34432.4271.28304.98
Free Cash Flow Per Share
0.040.050.020.280.170.27
Dividend Per Share
0.0130.0130.010---
Dividend Growth
-30.00%----
Gross Margin
18.55%24.00%31.66%29.69%35.83%27.62%
Operating Margin
9.34%12.82%16.78%13.87%19.20%-2.87%
Profit Margin
6.28%8.83%16.42%9.85%12.90%-7.27%
Free Cash Flow Margin
4.62%9.10%7.29%13.99%9.06%12.60%
EBITDA
933.2798569.05439.94585.76-62.09
EBITDA Margin
9.78%13.30%17.27%14.23%19.57%-2.57%
D&A For EBITDA
41.7828.7916.411.2111.227.44
EBIT
891.42769.21552.65428.73574.54-69.53
EBIT Margin
9.34%12.82%16.78%13.87%19.20%-2.87%
Effective Tax Rate
29.28%29.33%6.00%29.55%30.00%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.